LIWANLI Innovation Co Ltd (3054) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.056x

Based on the latest financial reports, LIWANLI Innovation Co Ltd (3054) has a cash flow conversion efficiency ratio of -0.056x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-41.53 Million ≈ $-1.31 Million USD) by net assets (NT$743.29 Million ≈ $23.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

LIWANLI Innovation Co Ltd - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how LIWANLI Innovation Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 3054 total debt and obligations for a breakdown of total debt and financial obligations.

LIWANLI Innovation Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of LIWANLI Innovation Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Answer Technology Co Ltd TW:3528	-0.720x
Ubiquoss Holdings Inc KQ:078070	0.055x
Suryamas Dutamakmur Tbk JK:SMDM	-0.014x
Helloworld Travel Ltd AU:HLO	-0.022x
Omiris AG F:HBD1	N/A
CareRx Corp TO:CRRX	0.073x
Sea Sonic Electronics Co Ltd TWO:6203	0.075x
Seronics Co. Ltd KQ:042600	-0.029x

Annual Cash Flow Conversion Efficiency for LIWANLI Innovation Co Ltd (2005–2024)

The table below shows the annual cash flow conversion efficiency of LIWANLI Innovation Co Ltd from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see 3054 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$752.96 Million ≈ $23.72 Million	NT$14.20 Million ≈ $447.44K	0.019x	+129.36%
2023-12-31	NT$783.51 Million ≈ $24.68 Million	NT$-50.34 Million ≈ $-1.59 Million	-0.064x	-162.66%
2022-12-31	NT$765.36 Million ≈ $24.11 Million	NT$78.48 Million ≈ $2.47 Million	0.103x	+250.54%
2021-12-31	NT$897.52 Million ≈ $28.28 Million	NT$-61.13 Million ≈ $-1.93 Million	-0.068x	-74.07%
2020-12-31	NT$936.03 Million ≈ $29.49 Million	NT$-36.63 Million ≈ $-1.15 Million	-0.039x	+65.38%
2019-12-31	NT$965.79 Million ≈ $30.43 Million	NT$-109.16 Million ≈ $-3.44 Million	-0.113x	+5.90%
2018-12-31	NT$1.02 Billion ≈ $32.29 Million	NT$-123.09 Million ≈ $-3.88 Million	-0.120x	-291.91%
2017-12-31	NT$1.53 Billion ≈ $48.34 Million	NT$96.03 Million ≈ $3.03 Million	0.063x	-15.97%
2016-12-31	NT$1.51 Billion ≈ $47.66 Million	NT$112.68 Million ≈ $3.55 Million	0.074x	+138.61%
2015-12-31	NT$1.09 Billion ≈ $34.36 Million	NT$34.04 Million ≈ $1.07 Million	0.031x	-91.83%
2014-12-31	NT$1.24 Billion ≈ $39.01 Million	NT$473.04 Million ≈ $14.90 Million	0.382x	+686.36%
2013-12-31	NT$1.38 Billion ≈ $43.43 Million	NT$-89.82 Million ≈ $-2.83 Million	-0.065x	+52.82%
2012-12-31	NT$753.19 Million ≈ $23.73 Million	NT$-104.02 Million ≈ $-3.28 Million	-0.138x	+30.01%
2011-12-31	NT$799.59 Million ≈ $25.19 Million	NT$-157.77 Million ≈ $-4.97 Million	-0.197x	-325.30%
2010-12-31	NT$895.33 Million ≈ $28.21 Million	NT$78.41 Million ≈ $2.47 Million	0.088x	+9.91%
2009-12-31	NT$1.12 Billion ≈ $35.36 Million	NT$89.43 Million ≈ $2.82 Million	0.080x	+4.20%
2008-12-31	NT$666.68 Million ≈ $21.00 Million	NT$50.98 Million ≈ $1.61 Million	0.076x	-3.33%
2005-12-31	NT$462.99 Million ≈ $14.59 Million	NT$36.62 Million ≈ $1.15 Million	0.079x	--

About LIWANLI Innovation Co Ltd

TW:3054 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$167.70 Million

NT$5.32 Billion TWD

Market Cap Rank

#17190 Global

#861 in Taiwan

Share Price

NT$66.00

Change (1 day)

-1.93%

52-Week Range

NT$22.10 - NT$90.30

All Time High

NT$90.30